我国医用同位素药物研发平台取得新进展

Core Insights - The "IP-SAFE project," led by the Institute of Modern Physics of the Chinese Academy of Sciences, has made significant progress with the successful installation of the main accelerator device, marking a crucial step in the construction of the world's first alpha medical isotope mass production demonstration facility based on a superconducting linear accelerator [1] Group 1 - The project aims to achieve large-scale production of medical alpha isotopes, specifically actinium-225 and radium-223, which are in global short supply [1] - The initiative seeks to address China's long-term reliance on imports for high-end medical nuclear isotopes [1] - The project leverages the Institute's technological expertise in high-current superconducting linear accelerators, high-power targets, and isotope separation [1]